CA2344107A1 - Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases - Google Patents
Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases Download PDFInfo
- Publication number
- CA2344107A1 CA2344107A1 CA002344107A CA2344107A CA2344107A1 CA 2344107 A1 CA2344107 A1 CA 2344107A1 CA 002344107 A CA002344107 A CA 002344107A CA 2344107 A CA2344107 A CA 2344107A CA 2344107 A1 CA2344107 A1 CA 2344107A1
- Authority
- CA
- Canada
- Prior art keywords
- leu
- ser
- val
- gly
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10170698P | 1998-09-25 | 1998-09-25 | |
US60/101,706 | 1998-09-25 | ||
PCT/EP1999/006991 WO2000018912A2 (en) | 1998-09-25 | 1999-09-21 | Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2344107A1 true CA2344107A1 (en) | 2000-04-06 |
Family
ID=22285989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002344107A Abandoned CA2344107A1 (en) | 1998-09-25 | 1999-09-21 | Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1115865A2 (ja) |
JP (1) | JP2002525111A (ja) |
AU (1) | AU5980499A (ja) |
CA (1) | CA2344107A1 (ja) |
WO (1) | WO2000018912A2 (ja) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6759515B1 (en) | 1997-02-25 | 2004-07-06 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
DE69935782T3 (de) | 1998-02-05 | 2017-01-05 | University Of Maryland, Baltimore | Brustkrebsresistenzprotein (BCRP) und für dieses kodierende DNA |
EP2311490A3 (en) | 1998-07-13 | 2011-05-04 | Board of Regents, The University of Texas System | Uses of antibodies to aminophospholipids for cancer treatment |
US6617122B1 (en) * | 1999-03-15 | 2003-09-09 | Xenon Genetics, Inc. | Process for identifying modulators of ABC1 activity |
EP1854880A1 (en) * | 1999-03-15 | 2007-11-14 | University of British Columbia | Methods and reagents for modulating cholesterol levels |
US6821774B1 (en) | 1999-06-18 | 2004-11-23 | Cv Therapeutics, Inc. | Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1 |
US6835563B1 (en) | 1999-06-18 | 2004-12-28 | Cv Therapeutics | Compositions and methods for increasing cholesterol efflux and raising HDL ATP binding cassette transporter protein ABC1 |
FR2796808B1 (fr) * | 1999-07-30 | 2004-03-12 | Inst Nat Sante Rech Med | Nouvelles applications des transporteurs de type abca |
WO2001032184A2 (en) * | 1999-11-01 | 2001-05-10 | Wisconsin Alumni Research Foundation | Abc1 modulation for the modulation of cholesterol transport |
US6830913B1 (en) * | 1999-11-29 | 2004-12-14 | Active Pass Pharmaceuticals, Inc. | ABCB9 transporter and uses thereof |
WO2001053490A1 (en) * | 2000-01-24 | 2001-07-26 | Warner-Lambert Company | Genes encoding abc1 paralogs and the polypeptides derived therefrom |
EP1136552A1 (en) * | 2000-03-20 | 2001-09-26 | Bayer Aktiengesellschaft | ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
EP1136554A1 (en) * | 2000-03-24 | 2001-09-26 | Bayer Aktiengesellschaft | ATP binding cassette transporter 1 (ABC1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
AU2001244196A1 (en) * | 2000-03-20 | 2001-10-03 | Bayer Aktiengesellschaft | Atp binding cassette transporter 1 (abc1) gene polymorphisms and uses thereof for the diagnosis and treatment of lipid disorders, cardiovascular diseases and inflammatory diseases |
EP1268787A2 (en) * | 2000-03-30 | 2003-01-02 | MERCK PATENT GmbH | Human tap-like protein (transporter associated in antigen processing/presentation) |
WO2001092523A2 (en) * | 2000-05-30 | 2001-12-06 | Curagen Corporation | Human polynucleotides and polypeptides encoded thereby |
US6855812B2 (en) | 2001-03-19 | 2005-02-15 | Becton, Dickinson And Company | P-glycoproteins and uses thereof |
ES2459218T3 (es) | 2006-05-12 | 2014-05-08 | Solvo Biotechnology | Sistema de ensayo para proteínas transportadoras |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994022846A1 (en) * | 1993-03-30 | 1994-10-13 | Pfizer Inc. | Compounds enhancing antitumor activity of other cytotoxic agents |
JP2002514903A (ja) * | 1996-06-17 | 2002-05-21 | ジンザイム コーポレイション | 新規のヒト第16染色体遺伝子、組成物、それを作製および使用する方法 |
AU742094B2 (en) * | 1997-02-27 | 2001-12-20 | Baylor College Of Medicine | Nucleic acid sequences for ATP-binding cassette transporter |
-
1999
- 1999-09-21 CA CA002344107A patent/CA2344107A1/en not_active Abandoned
- 1999-09-21 WO PCT/EP1999/006991 patent/WO2000018912A2/en not_active Application Discontinuation
- 1999-09-21 JP JP2000572359A patent/JP2002525111A/ja active Pending
- 1999-09-21 EP EP99969740A patent/EP1115865A2/en not_active Withdrawn
- 1999-09-21 AU AU59804/99A patent/AU5980499A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002525111A (ja) | 2002-08-13 |
EP1115865A2 (en) | 2001-07-18 |
WO2000018912A3 (en) | 2000-08-17 |
WO2000018912A2 (en) | 2000-04-06 |
AU5980499A (en) | 2000-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2344107A1 (en) | Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases | |
JP4726302B2 (ja) | Abc1ポリペプチドおよびコレステロール水準を調節する方法と試薬 | |
Jokinen et al. | Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle | |
US6221660B1 (en) | DNA encoding SNORF25 receptor | |
US20110288034A1 (en) | Methods of identifying adipocyte specific genes, the genes identified, and their uses | |
JPH1198988A (ja) | ヒト7膜貫通受容体をコードするcDNAクローンHEOAD54 | |
JP2002512781A (ja) | Gタンパク質共役型7tm受容体(axor−1) | |
US6703485B2 (en) | Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof | |
JP2002199893A (ja) | Gタンパク質共役型受容体hfiao41 | |
JPH11169187A (ja) | 新規化合物 | |
JP2000083669A (ja) | Cxcr4ケモカイン受容体のヒトスプライス変異体cxcr4b | |
JPH11123085A (ja) | 新規なgタンパク質共役受容体h7tba62 | |
JPH11235184A (ja) | ヒト7回膜貫通受容体をコードするcDNAクローンHNEAA8 1 | |
US20030105318A1 (en) | DNA encoding SNORF33 receptor | |
US6551821B1 (en) | Brain cyclic nucleotide gated ion channel and uses thereof | |
CA2482810C (en) | Teneurin c-terminal associated peptides (tcap) and methods and uses thereof | |
AU781228B2 (en) | DNA encoding human vanilloid receptor VR3 | |
JP2002504492A (ja) | Gタンパク質共役型受容体Fishboy | |
CA2327355A1 (en) | Human receptor molecules | |
JPH1118788A (ja) | Gタンパク質共役受容体 hofnh30 | |
JP2000502246A (ja) | 脊椎動物Deltexタンパク質、核酸および抗体ならびに関連方法および組成物 | |
JPH11127868A (ja) | 7tm受容体 hlwar77 | |
JPH1175866A (ja) | マウスFrizzled−6 遺伝子に類似したヒト7TM受容体 | |
JPH11511030A (ja) | 新規なヒトg−蛋白質結合レセプター | |
JP2000078994A (ja) | 新規7―トランスメンブラン受容体をコ―ドしているcDNAクロ―ンHNFDY20 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |